To analyze the relationship between CD70 mRNA expression and presence of CAFs, we used published gene sets identifying general CAFs and CAFs associated with immune checkpoint blockade (ICB) therapy resistance to estimate their numbers in CRC (i.e., COAD/READ) and PDAC (i.e., PAAD) [26]. The gene discussed is CD70; the disease is pancreatic adenocarcinoma.